Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedJun 19, 2026
DataAggregated Company Financials
Companies5
  • 7D-0.9%
  • 3M-3.9%
  • 1Y-34.6%
  • YTDn/a

Last week, the Drug Retail industry hasn't moved much but We Can Medicines is up 5.4% in that time. Unfortunately though, the industry is down 36% over the past 12 months. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 19 Jun 2026NT$20.0bNT$34.3bNT$765.8m22.6x26.1x0.6x
Sun, 17 May 2026NT$19.1bNT$34.3bNT$765.8m21.8x25x0.6x
Tue, 14 Apr 2026NT$20.7bNT$34.3bNT$687.6m19.9x30.1x0.6x
Thu, 12 Mar 2026NT$21.2bNT$34.2bNT$695.1m20.7x30.5x0.6x
Sat, 07 Feb 2026NT$23.3bNT$33.9bNT$712.6m21.9x32.8x0.7x
Mon, 05 Jan 2026NT$21.7bNT$33.9bNT$712.6m19.9x30.5x0.6x
Wed, 03 Dec 2025NT$22.7bNT$33.9bNT$712.6m21.3x31.9x0.7x
Fri, 31 Oct 2025NT$25.5bNT$33.5bNT$755.9m25.2x33.7x0.8x
Sun, 28 Sep 2025NT$28.5bNT$33.5bNT$755.9m28.9x37.8x0.9x
Tue, 26 Aug 2025NT$31.6bNT$33.5bNT$755.9m32.3x41.8x0.9x
Thu, 24 Jul 2025NT$31.4bNT$32.8bNT$754.7m27.2x41.6x1x
Sat, 21 Jun 2025NT$30.4bNT$32.8bNT$754.7m28.4x40.3x0.9x
Mon, 19 May 2025NT$32.8bNT$32.8bNT$754.7m30.5x43.4x1x
Wed, 16 Apr 2025NT$35.7bNT$32.3bNT$718.2m38.6x49.7x1.1x
Fri, 14 Mar 2025NT$38.0bNT$32.1bNT$741.0m45.5x51.3x1.2x
Sun, 09 Feb 2025NT$34.1bNT$31.8bNT$755.8m42.4x45.1x1.1x
Tue, 07 Jan 2025NT$32.2bNT$31.8bNT$755.8m43.3x42.6x1x
Thu, 05 Dec 2024NT$36.3bNT$31.8bNT$755.8m46.5x48.1x1.1x
Sat, 02 Nov 2024NT$39.5bNT$31.4bNT$774.1m112.7x51.1x1.3x
Mon, 30 Sep 2024NT$40.4bNT$31.0bNT$840.8m114x48.1x1.3x
Wed, 28 Aug 2024NT$41.5bNT$31.0bNT$840.8m112.8x49.3x1.3x
Fri, 26 Jul 2024NT$44.2bNT$30.7bNT$873.1m80.3x50.6x1.4x
Sun, 23 Jun 2024NT$46.5bNT$30.7bNT$873.1m81x53.2x1.5x
Tue, 21 May 2024NT$48.3bNT$30.7bNT$873.1m83.6x55.4x1.6x
Thu, 18 Apr 2024NT$49.5bNT$30.3bNT$935.7m58.9x52.9x1.6x
Sat, 16 Mar 2024NT$54.5bNT$30.3bNT$974.4m57.4x55.9x1.8x
Mon, 12 Feb 2024NT$56.3bNT$29.9bNT$964.0m62x58.4x1.9x
Wed, 10 Jan 2024NT$52.6bNT$26.8bNT$949.0m58.2x55.4x2x
Fri, 08 Dec 2023NT$53.4bNT$26.8bNT$949.0m59.1x56.3x2x
Sun, 05 Nov 2023NT$53.3bNT$26.3bNT$1.0b45.6x52.2x2x
Tue, 03 Oct 2023NT$54.7bNT$26.3bNT$1.0b47.4x53.6x2.1x
Thu, 31 Aug 2023NT$53.4bNT$26.3bNT$1.0b46.7x52.3x2x
Sat, 29 Jul 2023NT$55.4bNT$26.7bNT$1.3b26.8x43.9x2.1x
Mon, 26 Jun 2023NT$50.2bNT$26.8bNT$1.3b23.5x39.8x1.9x
Price to Earnings Ratio

39.8x


Total Market Cap: NT$50.2bTotal Earnings: NT$1.3bTotal Revenue: NT$26.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 44.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 26.1x which is lower than its 3-year average PE of 44.6x.
  • The 3-year average PS ratio of 1.3x is higher than the industry's current PS ratio of 0.58x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 15% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market7.79%
Consumer Staples-1.01%
Food and Staples Retail-2.00%
Drug Retail-0.94%
Big Box Super Stores0%0
Food Distributors-1.72%
Food Retail-2.09%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6929 We Can MedicinesNT$24.505.4%
+NT$56.4m		-26.9%PS0.3x
6844 Norbel BabyNT$65.901.7%
+NT$41.2m		-34.8%PE25.3x
4175 MedFirst Healthcare ServicesNT$53.701.5%
+NT$33.9m		-18.6%PE17.5x
7731 MARX BiotechNT$5.570.2%
+NT$5.2m		2.6%PE67.7x

Latest News

6844
NT$65.90
Norbel Baby
7D
1.7%
1Y
-34.8%
4175
NT$53.70
MedFirst Healthcare Services
7D
1.5%
1Y
-18.6%
6929
NT$24.50
We Can Medicines
7D
5.4%
1Y
-26.9%
6469
NT$74.90
Great Tree Pharmacy
7D
-2.6%
1Y
-42.8%
7731
NT$5.57
MARX Biotech
7D
0.2%
1Y
2.6%